Register your Account

Sign Up with us and Enjoy!
User name Email First Name Last Name Contact info

A password will be e-mailed to you.


NEW YORK, December 18, 2012 (MESHPRESS) – Marketsareopen, one of the leaders in providing investment alerts on U.S. stocks are announcing Investment Highlights on Top NYSE Active Stocks:-

Smith & Wesson Holding Corporation(NASDAQ:SWHC) stock decreased 8.40% to $7.92. The company posted a second-quarter profit $21.18 million, as compared to a loss of $1.59 million in the year ago quarter. Net income from continuing operations for the second quarter was $16.40 million, or $0.24 per share, compared with net income from continuing operations of $948 thousand, or $0.01 per share, for the second quarter last year. Net sales from continuing operations for the second quarter were $136.6 million, up 48% from $92.29 million in the year-ago quarter. Analysts expected the company to report a earnings of $0.24 per share on revenues of $134.78 million for the quarter.

How Should Investors Trade SWHC After Today’s Rally? Find Out Here

Somaxon Pharmaceuticals, Inc.(NASDAQ:SOMX) stock increased 1.69% to $3.10. The company announced that its licensee Paladin Labs Inc. (TSX:PLB) has received approval from Health Canada of Paladin’s New Drug Submission (NDS) for Silenor (doxepin) for the treatment and symptomatic relief of insomnia characterized by frequent nocturnal awakening and/or early morning awakenings.

Get Free Trend Analysis on SOMX Here

VIVUS, Inc.(NASDAQ:VVUS) stock decreased 0.73% to $12.98.  The company reported improved sales performance in weekly prescriptions for its Qsymia pill; a weight loss prescription medication for obese adults. Two health care research firms released reports indicating that the sales of Qsymia increased in November, but their figures were different. Data from Symphony Health Solutions showed Qsymia’s sales for the week that ended November 12 jumped by 44%.

Get Free Trend Analysis on VVUS Here

Arena Pharmaceuticals, Inc.(NASDAQ:ARNA) shares gained 0.97% to $9.34. The company announced that it has entered into a co-development and license agreement with Ildong Pharmaceutical Co., Ltd., for temanogrel, Arena’s internally discovered inverse agonist of the serotonin 2A receptor.

Additionally, the company is seeing activity after its Lorcaserin was proposed for DEA Schedule IV placement. The Drug Enforcement Administration (DEA) proposes placing the substance lorcaserin, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible, into Schedule IV of the Controlled Substances Act (CSA).

Get Free Trend Analysis on ARNA Here

Highway Holdings Limited(NASDAQ:HIHO) stock climbed 3.33% to $1.86. The company announced its automation equipment manufacturing joint venture has received orders with an aggregate value of approximately $1.1 million during the past few months from five separate companies located in Shanghai and the Great Pearl River Delta regions that operate within the automotive, white goods, consumer products and component manufacturing sectors.

Get Free Trend Analysis on HIHO Here

About Marketsareopen

Marketsareopen’s team is engaged in providing valuable and updated news information on U.S. stocks on a regular basis. Marketsareopen’s instant stock news on Major Gainers, Hot Stocks and various other stocks, guides investors in making the wise stock market investments decision. To Get Instant updates in the inbox, readers are advised to sign up for free at


The assembled information disseminated by is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. does expect that investors will buy and sell securities based on information assembled and presented in PLEASE always do your own due diligence, and consult your financial advisor.



Related Press realease: